Anticancer compounds and sphingolipid metabolism in the colon

Area of Science:

• Biochemistry
• Molecular Biology
• Oncology

Background:

• Sphingomyelin metabolism yields anticancer signals, including ceramide and sphingosine, which can inhibit cell proliferation and induce apoptosis.
• Alterations in sphingomyelin metabolism are linked to tumorigenesis across various tissues, with a notable association with colon cancer.
• There is growing interest in targeting sphingomyelin metabolism for novel anticancer drug development.

Purpose of the Study:

• To review the sphingomyelin metabolism pathway.
• To present evidence linking sphingomyelin metabolism to colon cancer.
• To summarize anticancer agents and dietary factors influencing sphingomyelin metabolism and its anticancer messengers in the colon.

Main Methods:

• Literature review of studies on sphingomyelin metabolism.
• Analysis of research linking sphingomyelin to colon cancer.
• Compilation of data on anticancer drugs and dietary factors affecting sphingomyelin metabolism.

Main Results:

• Sphingomyelin metabolism generates key anticancer molecules.
• Dysregulation of sphingomyelin metabolism is implicated in colon cancer development.
• Various anticancer drugs and dietary components modulate sphingomyelin metabolism.

Conclusions:

• Sphingomyelin metabolism plays a crucial role in colon cancer prevention and treatment.
• Targeting sphingomyelin metabolism offers a promising strategy for colon cancer therapy.
• Dietary interventions may influence sphingomyelin metabolism for anticancer effects in the colon.